Jane Street Group LLC Has $176,000 Stock Position in PetMed Express, Inc. (NASDAQ:PETS)

Jane Street Group LLC reduced its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 52.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 47,890 shares of the company’s stock after selling 52,276 shares during the quarter. Jane Street Group LLC’s holdings in PetMed Express were worth $176,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Federated Hermes Inc. increased its position in shares of PetMed Express by 54.5% during the second quarter. Federated Hermes Inc. now owns 606,430 shares of the company’s stock worth $2,456,000 after buying an additional 213,903 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in shares of PetMed Express during the second quarter worth $797,000. Bleakley Financial Group LLC acquired a new stake in shares of PetMed Express during the third quarter worth $279,000. Squarepoint Ops LLC acquired a new stake in shares of PetMed Express during the second quarter worth $273,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of PetMed Express during the second quarter worth $135,000. 73.33% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other PetMed Express news, Director Leslie C.G. Campbell acquired 15,000 shares of the company’s stock in a transaction on Wednesday, December 4th. The shares were purchased at an average cost of $5.38 per share, with a total value of $80,700.00. Following the completion of the purchase, the director now owns 70,000 shares of the company’s stock, valued at approximately $376,600. This represents a 27.27 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.10% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of PetMed Express from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th.

PetMed Express Stock Up 1.7 %

Shares of NASDAQ PETS opened at $4.85 on Tuesday. The firm has a market cap of $100.22 million, a PE ratio of -80.83 and a beta of 0.69. PetMed Express, Inc. has a 12-month low of $2.90 and a 12-month high of $7.25. The company’s fifty day simple moving average is $5.06 and its 200 day simple moving average is $4.16.

PetMed Express (NASDAQ:PETS) last issued its earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.17. The business had revenue of $59.57 million for the quarter, compared to analyst estimates of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. On average, equities analysts predict that PetMed Express, Inc. will post 0.24 earnings per share for the current year.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.